A phosphoglycoprotein associated with taxol resistance in J774.2 cells
- PMID: 2861892
A phosphoglycoprotein associated with taxol resistance in J774.2 cells
Abstract
Taxol is an inhibitor of cell replication that promotes the assembly of microtubules in vitro and in cells. In the murine macrophage-like cell line J774.2, a taxol-resistant subline (J7/TAX-50) has been developed in vitro by growing the cells in increasing drug concentrations. These cells, which are approximately 800-fold resistant to taxol, display some cross-resistance to colchicine, vinblastine, puromycin, doxorubicin, and actinomycin D but remain sensitive to bleomycin. Binding of radiolabeled drug to the resistant cells is reduced by approximately 90%. Resistant cells grown in the absence of drug for 10 days (J7/TAX-0D10), 1 month (J7/TAX-0D30), and 8 months (J7/TAX-0D240) regain a major portion (27, 92, and 99%, respectively) of their sensitivity to the drug. However, binding of the drug to the J7/TAX-0D30 and J7/TAX-0D240 cells is increased to only 20 and 70%, respectively, of that measured with sensitive cells. Analysis of plasma membranes by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by silver staining reveals the presence of a prominent protein with an approximate molecular weight of 135,000 in the resistant line that is essentially absent from the parental line and from both of the J7/TAX-0D30 and J7/TAX-0D240 lines. Although this protein can be seen in J7/TAX-0D10, its quantity is diminished. The Mr 135,000 protein is also observed in the resistant cells when they are labeled with [3H]leucine, [35S]methionine, [3H]glucosamine, or [32P]orthophosphate. Plasma membranes from colchicine- or vinblastine-resistant J774.2 cells also contain prominent phosphoglycoproteins, with approximate molecular weights of 145,000 and 150,000, respectively. Partial purification of the Mr 135,000 glycoprotein by agarose-bound ricinus communis agglutinin I-agarose affinity chromatography indicates that it accounts for approximately 4 to 5% of total membrane protein. A Mr 100,000 phosphoglycoprotein, present in the membranes of J774.2 cells is essentially absent in J7/TAX-50 cells after labeling with [3H]glucosamine or [32P]orthophosphate. Phosphoamino acid analysis of the Mr 135,000 and 100,000 phosphoglycoproteins reveals that the phosphorylation sites are serine and threonine residues. There appears to be a good correlation between the presence of the Mr 135,000 phosphoglycoprotein in plasma membranes and resistance to taxol.
Similar articles
-
Adriamycin resistance in HL60 cells and accompanying modification of a surface membrane protein contained in drug-sensitive cells.Cancer Res. 1987 Oct 1;47(19):5080-6. Cancer Res. 1987. PMID: 3621192
-
Expression of phenotypic traits following modulation of colchicine resistance in J774.2 cells.J Cell Physiol. 1986 May;127(2):253-60. doi: 10.1002/jcp.1041270210. J Cell Physiol. 1986. PMID: 3700481
-
Molecular/cytogenetic alterations accompanying the development of multidrug resistance in the J774.2 murine cell line.Leukemia. 1988 Jul;2(7):453-8. Leukemia. 1988. PMID: 2899184
-
Plant alkaloids.Cancer Chemother Biol Response Modif. 1990;11:74-81. Cancer Chemother Biol Response Modif. 1990. PMID: 1977436 Review. No abstract available.
-
Mechanism of action of taxol.Trends Pharmacol Sci. 1992 Apr;13(4):134-6. doi: 10.1016/0165-6147(92)90048-b. Trends Pharmacol Sci. 1992. PMID: 1350385 Review. No abstract available.
Cited by
-
Utilization of Photoaffinity Labeling to Investigate Binding of Microtubule Stabilizing Agents to P-Glycoprotein and β-Tubulin.J Nat Prod. 2022 Mar 25;85(3):720-728. doi: 10.1021/acs.jnatprod.2c00106. Epub 2022 Mar 3. J Nat Prod. 2022. PMID: 35240035 Free PMC article. Review.
-
Differential effect of taxol in rat primary and metastatic prostate tumors: site-dependent pharmacodynamics.Pharm Res. 1996 Sep;13(9):1305-12. doi: 10.1023/a:1016053412582. Pharm Res. 1996. PMID: 8893266
-
New microtubular agents in pediatric oncology.Invest New Drugs. 1996;14(1):49-54. doi: 10.1007/BF00173682. Invest New Drugs. 1996. PMID: 8880393 Review.
-
Molecular analysis of the multidrug transporter.Cytotechnology. 1993;12(1-3):33-62. doi: 10.1007/BF00744657. Cytotechnology. 1993. PMID: 7765331 Review.
-
Paclitaxel-2'-Ethylcarbonate prodrug can circumvent P-glycoprotein-mediated cellular efflux to increase drug cytotoxicity.Pharm Res. 2007 Mar;24(3):555-65. doi: 10.1007/s11095-006-9171-6. Pharm Res. 2007. PMID: 17245652